Acyclic Patents (Class 514/663)
  • Patent number: 5843865
    Abstract: Compositions comprising an ionene polymer and a salt of dodecylamine are disclosed which are synergistically effective compared to the respective components alone in controlling the growth of microorganisms in or on a material or medium. Methods to control the growth of microorganisms with the use of the compositions of the present invention are also disclosed.
    Type: Grant
    Filed: February 6, 1997
    Date of Patent: December 1, 1998
    Assignee: Buckman Laboratories International, Inc.
    Inventors: Fernando Del Corral, Percy Jaquess, David Oppong
  • Patent number: 5824650
    Abstract: The invention relates to a therapeutic composition for topical application containing at least one product with an irritant side effect and a substance P antagonist for reducing or even eliminating the irritant effect of this product.It also relates to the use of a substance P antagonist for the preparation of a pharmaceutical composition for topical application containing at least one product with an irritant side effect for reducing or even eliminating the irritant effect of this product.The substance P antagonist may be a peptide compound or a nitrogen-containing compound or a nitrogen-, sulphur- or oxygen-containing heterocyclic compound.
    Type: Grant
    Filed: December 19, 1995
    Date of Patent: October 20, 1998
    Assignee: L'Oreal
    Inventors: Olivier De Lacharriere, Lionel Breton
  • Patent number: 5766617
    Abstract: A trapping system for capturing male and female frugivorous pest insects for detecting, monitoring, and/or controlling that includes an attractant composition of ammonium acetate and putrescine and a synergist for the attractant composition.
    Type: Grant
    Filed: August 23, 1996
    Date of Patent: June 16, 1998
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: Robert R. Heath, Nancy D. Epsky
  • Patent number: 5760091
    Abstract: A preventive agent against adhesion of a marine organism comprising: at least one amine compound represented by the following formula (I): ##STR1## , wherein R is a C.sub.8-22 saturated or unsaturated aliphatic hydrocarbon group, R.sup.1 is hydrogen atom, aminopropyl, a C.sub.1-22 saturated aliphatic hydrocarbon or C.sub.2-22 unsaturated aliphatic hydrocarbon group, R.sup.2 is aminopropyl, a C.sub.1-8 saturated aliphatic hydrocarbon or C.sub.2-8 unsaturated aliphatic hydrocarbon group, provided that R.sup.1 is hydrogen atom or aminopropyl group when R.sup.2 is represents aminopropyl group, or a salt thereof; and at least one N-alkyl polyamine compound represented by the following formula (II):R--?NH(CH.sub.2).sub.3 !.sub.n --NH.sub.2 (II), wherein R is a C.sub.8-22 saturated or unsaturated aliphatic hydrocarbon group and n is an integer from 2 to 4, or a salt thereof in an amount of 0.1 to 9 parts by weight to one part by weight of the compound (I).
    Type: Grant
    Filed: March 20, 1996
    Date of Patent: June 2, 1998
    Assignee: Katayama Chemical, Inc.
    Inventors: Yoshiharu Wakao, Toru Yasunaga
  • Patent number: 5681859
    Abstract: A non-toxic, environmentally safe and easily employable insecticide and insect repellant is achieved by providing an aqueous composition incorporating ethanolamine based compounds, either independently or in combination with the ethanolamine based compounds being selected from both simple compounds and conjugated compounds. In one preferred embodiment, a highly effective composition is attained for safe, effective, direct topical application to humans and animals by employing between about 10% and 70% by volume of the entire composition of the ethanolamine-based compound. In alternate preferred embodiments, the insecticide is formulated for application to plants, trees, crops, and other vegetation to provide a composition which effectively controls bothersome insects, while being completely safe and non-injurious to the plant, tree, or crop, as well as to the flowers or fruit thereof.
    Type: Grant
    Filed: September 6, 1995
    Date of Patent: October 28, 1997
    Assignee: Lynn Sue James
    Inventors: Lynn Sue James, Michael A. Siedman
  • Patent number: 5679363
    Abstract: Method for the preparation of an insect attractant composition which includes a trialkylamine salt, an alkali salt of a carboxylic acid and a pheromone in a suitable aqueous solution.
    Type: Grant
    Filed: November 29, 1994
    Date of Patent: October 21, 1997
    Assignee: Sandoz Ltd.
    Inventors: Kim W. Yang, David R. Kinzer, Ronald B. Winslow
  • Patent number: 5656608
    Abstract: Composition comprising glycine and/or other amino acids are useful in treating or minimizing the effects of endotoxemia, hypoxia-reperfusion injury and infection.
    Type: Grant
    Filed: February 23, 1995
    Date of Patent: August 12, 1997
    Assignee: Sandoz Nutrition Ltd.
    Inventors: Heinz Schneider, Ronald G. Thurman
  • Patent number: 5631292
    Abstract: Ingestible compounds which are substantially tasteless and which have been found to be effective reducers or eliminators of undesirable tastes for eatables.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: May 20, 1997
    Assignee: Bioresearch, Inc.
    Inventors: Robert J. Kurtz, William D. Fuller
  • Patent number: 5622995
    Abstract: A method is provided for controlling the proliferation of molluscs in target habitat by applying to the habitat a compound or mixture of compounds which are amines, ethoxylated amines, quaternary amines, ethoxylated quaternary amines and cyclic amines.
    Type: Grant
    Filed: August 15, 1994
    Date of Patent: April 22, 1997
    Assignee: Electric Power Research Institute, Inc.
    Inventors: Billy D. Fellers, Arthur J. Freedman, Thomas M. Laronge
  • Patent number: 5614558
    Abstract: A non-toxic, environmentally safe and easily employable insecticide and insect repellant is achieved by providing an aqueous composition incorporating ethanolamine based compounds, either independently or in combination with the ethanolamine based compounds being selected from both simple compounds and conjugated compounds. In one preferred embodiment, a highly effective composition is attained for safe, effective, direct topical application to humans and animals by employing between about 10% and 70% by volume of the entire composition of the ethanolamine-based compound. In alternate preferred embodiments, the insecticide is formulated for application to plants, trees, crops, and other vegetation to provide a composition which effectively controls bothersome insects, while being completely safe and non-injurious to the plant, tree, or crop, as well as to the flowers or fruit thereof.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: March 25, 1997
    Assignee: Lynn Sue James
    Inventors: Lynn S. James, Michael A. Siedman
  • Patent number: 5516807
    Abstract: Polyamines inhibit vascular smooth muscle proliferation and thus are useful in treating and preventing vascular proliferative disorders such as restenosis following balloon angioplasty.
    Type: Grant
    Filed: October 25, 1994
    Date of Patent: May 14, 1996
    Assignee: Warner-Lambert Company
    Inventors: Donald Hupe, Joan A. Keiser
  • Patent number: 5494935
    Abstract: Several new powerful chelating agents, suitable for the removal of a variety of certain heavy metal ions from the body of a mammal by oral application, have been synthesized and tested. Structurally, these compounds are partially lipophilic polyaminocarboxylic acids (PACA). They were synthesized in non-aqueous media from triethylenetetramine (TT) by monoalkylation of a primary amino group, followed by exhaustive carboxymethylation of the remaining amino groups using ethylbromoacetate and subsequent alkaline hydrolysis of the ester. In contrast to their non-lipophilic counterparts EDTA and DTPA, compositions of the present inventions exhibit appreciable absorption from the intestine and, therefore, can be administered orally. By varying the length of the alkyl chain, the chelons can be directed primarily to selected target organs. In addition, the compounds can be modified to target particular absorbed heavy metals.
    Type: Grant
    Filed: April 3, 1995
    Date of Patent: February 27, 1996
    Assignee: University of Utah Research Foundation
    Inventors: Scott C. Miller, Friedrich W. Bruenger
  • Patent number: 5444093
    Abstract: Wood preservatives contain a copper salt, a polyamine and a fatty amine and are used for preserving wood from fungi and termites.
    Type: Grant
    Filed: November 3, 1993
    Date of Patent: August 22, 1995
    Assignee: Dr. Wolman GmbH
    Inventors: Reimer Goettsche, Hans-Volker Borck
  • Patent number: 5436241
    Abstract: The composition contains: an antiinflammatory effective amount of piroxicam; an amount of tetrahydroxypropylethylenediamine sufficient to solubilize the piroxicam in the composition; an amount of C.sub.2 -C.sub.6 alkylene glycol, or mixture thereof, sufficient to detackify the composition and provide humectancy; about 0.2% to about 2% carbomer; about 30% to about 60% C.sub.2 -C.sub.4 alkanol; and water qs to 100%. Hydroxypropylcellulose can be added to the composition.
    Type: Grant
    Filed: January 14, 1994
    Date of Patent: July 25, 1995
    Assignee: Bristol-Myers Squibb Company
    Inventors: Chung Shin, Luc Bossuyt
  • Patent number: 5403862
    Abstract: Several new powerful chelating agents, suitable for the removal of a variety of certain heavy metal ions from the body by oral application, have been synthesized and tested. Structurally, these compounds are partially lipophilic polyaminocarboxylic acids (PACA). They were synthesized in non-aqueous media from triethylenetetramine (TT) by monoalkylation of a primary amino group, followed by exhaustive carboxymethylation of the remaining amino groups using ethylbromoacetate and subsequent alkaline hydrolysis of the ester. Gel permeation chromatography of a mixture of the PACA and actinide elements have shown these substances to be strong chelating agents similar to EDTA or DTPA. In contrast to their non-lipophilic counterparts EDTA and DTPA, compositions of the present inventions exhibit appreciable absorption from the intestine and, therefore, can be administered orally. By varying the length of the alkyl chain, the chelons can be directed primarily to selected target organs.
    Type: Grant
    Filed: January 17, 1992
    Date of Patent: April 4, 1995
    Assignee: University of Utah Research Foundation
    Inventors: Scott C. Miller, Friedrich W. Bruenger
  • Patent number: 5399344
    Abstract: Method for the preparation of an insect attractant composition which includes a trialkylamine salt, an alkali salt of a carboxylic acid and a pheromone in a suitable aqueous solution.
    Type: Grant
    Filed: April 16, 1992
    Date of Patent: March 21, 1995
    Assignee: Sandoz Ltd.
    Inventors: Kim W. Yang, David R. Kinzer, Ronald B. Winslow
  • Patent number: 5322834
    Abstract: This invention relates to synergistic antimicrobial and biocidal compositions comprising 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one and one or more commercial biocides for more effective, and broader control of microorganisms in various industrial systems.
    Type: Grant
    Filed: October 21, 1993
    Date of Patent: June 21, 1994
    Assignee: Rohm and Haas Company
    Inventor: Jemin C. Hsu
  • Patent number: 5292497
    Abstract: A method of decreasing the toxicity of chemical therapeutic agents administered in cancer chemotherapy including adminstration to a patient undergoing chemotherapy. This reduction in toxicity can be accomplished by administering an effective amount of S-3-(3-methylaminopropylamino)propyl dihydrogen phosphorothioate. Methods of inducing mucolytic activity and reducing toxicity of acetominophen overdose are also discussed. Such activities are induced through the administration of S-3-(3-methylaminopropylamino)propyl dihydrogen phosphorothioate.
    Type: Grant
    Filed: March 29, 1993
    Date of Patent: March 8, 1994
    Assignee: U.S. Bioscience, Inc.
    Inventors: Philip S. Schein, James R. Piper
  • Patent number: 5276029
    Abstract: Wood preservatives contain a copper salt, a polyamine and a fatty amine and are used for preserving wood from fungi and termites.
    Type: Grant
    Filed: November 1, 1990
    Date of Patent: January 4, 1994
    Assignee: Dr. Wolman GmbH
    Inventors: Reimer Goettsche, Hans-Volker Borck
  • Patent number: 5248494
    Abstract: A lenitive composition is provided for application to the skin of an anthralin patient for reducing anthralin-induced inflammation and the staining associated with anthralin use. The lenitive composition is a single phase aqueous treating solution comprising an organic amine and a film-forming agent dissolved within a nontoxic dermatologically acceptable carrier. The organic amine is selected from the group consisting of lower alkyl and lower alkanol primary, secondary and tertiary amines and comprises about 1 to 25 percent by weight of the single phase aqueous treating solution. The solution is topically applied to the anthralin-treated areas so as to completely cover the treated areas. The solution is applied before or after anthralin wash off, preferably in the form of a fine spray or mist.
    Type: Grant
    Filed: June 10, 1992
    Date of Patent: September 28, 1993
    Assignee: Young Pharmaceuticals Inc.
    Inventors: John E. Kuleza, Lawrence Clifford M., Sam Shuster
  • Patent number: 5202482
    Abstract: The present invention arises from the discovery of an endogenous malignancy-associated catabolite characterized by (i) a molecular weight of about 135 daltons as determined by mass spectrum analysis; (ii) a UV absorption maximum at 237 nm; (iii) a 15 centimeter C18 HPLC column retention time of from about 1.00 to about 2.00 minutes as compared to a retention time at a 1 ml/minute flow rate of about 2.5 to about 3.0 minutes for an internal standard marker; (iv) containing no aromatic ring structures, containing one methyl group at the 1-position and one methyl group at the 6-position of an alpha carbon chain, and containing at least one nitrogen moiety as determined by nuclear magnetic resonance; and (v) being present in elevated amounts in the urine substantially exclusively of individuals suffering from malignant conditions.
    Type: Grant
    Filed: October 13, 1989
    Date of Patent: April 13, 1993
    Assignee: Oncologic Labs, Inc.
    Inventor: Bing D. Jiang
  • Patent number: 5186947
    Abstract: Water-soluble wood preservatives which contain mixtures of a metal compound, a metal-fixing acid and a complexing polymeric nitrogen compound, and methods for protecting wood with such mixtures.
    Type: Grant
    Filed: September 19, 1991
    Date of Patent: February 16, 1993
    Assignee: Dr. Wolman GmbH
    Inventors: Reimer Goettsche, Wolfgang Reuther
  • Patent number: 5179116
    Abstract: A wood preservative which is based on a dimethylalkylamine and an acid and contains dimethylalkylamine, a water-soluble acid and a water-insoluble acid and/or 2-(methoxycarbonylamino)-benzimidazole is used for preserving wood.
    Type: Grant
    Filed: June 5, 1992
    Date of Patent: January 12, 1993
    Assignee: Dr. Wolman GmbH
    Inventors: Reimer Goettsche, Hans-Volker Borck, Hans-Norbert Marx
  • Patent number: 5164416
    Abstract: A transdermal therapeutic formulation comprising d-limonene and at least one pharmaceutically active substance wherein the content of the d-limonene is in the range from 0.1 to 2 weight percent, based on the total amount of the formulation. The transdermal therapeutic formulation has an excellent percutaneous absorption, is safe and is capable of delivering desired pharmaceutically active substances to a desired location of treatment or to the entire body of a patient through the circulatory system and is thus effective for curing various diseases.
    Type: Grant
    Filed: May 8, 1991
    Date of Patent: November 17, 1992
    Assignee: Lintec Corporation
    Inventors: Tsuneji Nagai, Kozo Takayama, Hideaki Okabe
  • Patent number: 5124358
    Abstract: A method is described for blocking maturation and production of microfilariae in adult filarial nematodes utilizing a transglutaminase inhibitor, such as monodansyl cadaverine (MDC). Experiments applying this method to several Brugia filarial infections, including Brugia malayi, were successful. Higher concentration of transglutaminase inhibitor proved to be filariacidal.
    Type: Grant
    Filed: January 16, 1990
    Date of Patent: June 23, 1992
    Assignee: The Board of Reagents The University of Texas System
    Inventors: Mehta Kapil, Undaru R. Rao, Ann C. Vickery
  • Patent number: 5110831
    Abstract: The present invention relates to vinylogous hydroxamic acids, processes for their manufacture, pharmaceutical preparations containing them, and their use in the treatment of various disorders.
    Type: Grant
    Filed: November 30, 1990
    Date of Patent: May 5, 1992
    Assignee: Du Pont Merck Pharmaceutical Company
    Inventors: Ronald L. Magolda, Stephen W. Wright
  • Patent number: 5096930
    Abstract: This invention relates to a treatment for the improvement of regeneration of injured striated muscles, the key-feature of which is the application of n-butylamine, in natural or ionic form or in buffered solution, as effective substance.
    Type: Grant
    Filed: November 15, 1989
    Date of Patent: March 17, 1992
    Assignee: Ceskoslovenska akademie ved
    Inventors: Jan Zenka, Dagmar Hulinska, Radim Holusa, Theodor Pokorny, Alexandr Jegorov
  • Patent number: 5021459
    Abstract: Wood preservatives containing a dimethylalkylamine, tridemorph, fenpropemorph or a mixture thereof, an emulsifier and a water-insoluble acid or a salt thereof, and a method for protectin wood from fungi.
    Type: Grant
    Filed: November 1, 1989
    Date of Patent: June 4, 1991
    Assignee: Dr. Wolman GmbH
    Inventor: Reimer Goettsche
  • Patent number: 5021404
    Abstract: Angiostatic compounds are potentiated by collagen matrix metabolism modulators including:a) proline analogs which inhibit proline hydroxylation when substituted for proline in collagen;b) inhibitors of proline hydroxylase;c) inhibitors of collagen cross-linking; andd) all trans-retinoic acid.In methods and therapeutic compositions for inhibiting angiogenesis in a mammal, the collagen matrix modulator is administered with an angiostatic steroid or with heparin (including angiostatic heparin fragments of six or more sugar units, and synthetic fragments).
    Type: Grant
    Filed: April 20, 1988
    Date of Patent: June 4, 1991
    Assignee: The Children's Medical Center Corporation
    Inventors: Judah Folkman, Donald Ingber
  • Patent number: 5002930
    Abstract: The absorption rate of proteins with medicinal properties in the blood is enhanced by administering the protein intramuscularly together with an absorption enhancing agent, e.g. hydroxylamine or a salt thereof.
    Type: Grant
    Filed: February 27, 1987
    Date of Patent: March 26, 1991
    Assignee: Survival Technology, Inc.
    Inventors: Stanley J. Sarnoff, Burton E. Sobel
  • Patent number: 4968679
    Abstract: New 8-substituted 2-aminotetralins can be prepared from the corresponding aminotetralins or tetralones. They can be used in medicaments.
    Type: Grant
    Filed: May 22, 1989
    Date of Patent: November 6, 1990
    Assignee: Bayer Aktiengesellschaft
    Inventors: Bodo Junge, Bernd Richter, Thomas Glaser, Jorg Traber, George S. Allen
  • Patent number: 4906651
    Abstract: This invention relates to synergistic antimicrobial and biocidal compositions comprising 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one and one or more commercial biocides for more effective, and broader control of microorganisms in various industrial systems.
    Type: Grant
    Filed: December 22, 1988
    Date of Patent: March 6, 1990
    Assignee: Rohm and Haas Company
    Inventor: Jemin C. Hsu
  • Patent number: 4868219
    Abstract: Noninfectious inflammatory skin diseases in which bacteria or yeasts play a significant adjunctive role are treated with topical formulations of aliphatic amines containing 9 to 18 carbon atoms, and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: April 7, 1988
    Date of Patent: September 19, 1989
    Inventor: Carl R. Thornfeldt
  • Patent number: 4845130
    Abstract: Long chain alkyl amines are useful as anti-hyperlipidemic agents for lowering serum cholesterol and triglyceride levels in mammals. Such amines include compounds of the formula ##STR1## in which R.sub.1 is alkyl of 8 to 20 carbon atoms and each R.sub.2 is hydrogen or alkyl of 1 to 3 carbon atoms.
    Type: Grant
    Filed: April 18, 1988
    Date of Patent: July 4, 1989
    Assignee: United States Borax & Chemical Corporation
    Inventors: Iris H. Hall, Thomas S. Griffin, Edward L. Docks
  • Patent number: 4772585
    Abstract: The absorption rate of protein-thrombolytic agents with medicinal properties in the blood is enhanced by administering the protein intramuscularly together with an absorption enhancing agent, e.g. hydroxylamine or a salt thereof.
    Type: Grant
    Filed: October 1, 1985
    Date of Patent: September 20, 1988
    Assignee: Survival Technology, Inc.
    Inventors: Stanley J. Sarnoff, Burton E. Sobel